Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Antidepressants Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The antidepressants market has shown consistent growth in recent years. It is anticipated to expand from $17.9 billion in 2025 to $18.36 billion in 2026, at a compound annual growth rate (CAGR) of 2.6%. This historical growth can be linked to factors such as the increasing prevalence of depression, greater awareness surrounding mental health, the introduction of SSRI drugs, the expansion of healthcare infrastructure, and increased research and development in psychopharmacology.
The antidepressants market is projected to experience consistent expansion over the upcoming years. Its valuation is anticipated to reach $20.54 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 2.8%. This projected increase during the forecast period is driven by several factors, including developments in precision medicine, the incorporation of AI into mental health diagnostics, the increasing uptake of digital therapeutics, the broadening of telemedicine services, and a surge in demand for antidepressants among pediatric and geriatric populations. Key developments expected during this period encompass tailored antidepressant therapies, the proliferation of telepsychiatry and remote mental health provisions, the use of mobile health applications for monitoring mood, heightened awareness regarding mental health conditions, and an uptick in treatment for depression in elderly and younger individuals.
Get A Free Sample Report With In-Depth Market Insights:
Antidepressants Market Growth Drivers: What’s Behind The Acceleration?
The rising incidence of mental illness is anticipated to drive the demand for the antidepressants market moving forward. A mental illness is defined as a condition that influences an individual’s thinking, feeling, behavior, or beliefs, often stemming from distress or difficulties in social, work, or family interactions. Antidepressants are medications used to address various mental health concerns, including depression, anxiety, and mood disorders, by elevating the levels of specific brain chemicals responsible for regulating mood and emotions. For example, in October 2025, the Care Quality Commission (CQC), a UK-based independent regulator of health and adult social care in England, indicated that in 2024/25, there were an average of 453,930 new referrals to secondary mental health services each month, marking a 15% increase compared to 2022/23. Consequently, the increasing prevalence of mental illness will boost the antidepressants market.
Antidepressants Market Segment Performance And Emerging Opportunities
The antidepressants market covered in this report is segmented –
1) By Product: Selective Serotonin Reuptake Inhibitor (SSRI), Serotonin-norepinephrine Reuptake Inhibitor (SNRI), Tricyclic Antidepressant (TCA), Monoamine Oxidase Inhibitor (MAOI)
2) By Drug Class: Monoamine Oxidase Inhibitors, Serotonin Antagonist And Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants
3) By Depressive Disorder: Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder
Subsegments:
1) By Selective Serotonin Reuptake Inhibitor (SSRI): Fluoxetine, Sertraline, Escitalopram, Paroxetine, Citalopram
2) By Serotonin-norepinephrine Reuptake Inhibitor (SNRI): Venlafaxine, Duloxetine, Desvenlafaxine
3) By Tricyclic Antidepressant (TCA): Amitriptyline, Nortriptyline, Imipramine, Doxepin
4) By Monoamine Oxidase Inhibitor (MAOI): Phenelzine, Tranylcypromine, Isocarboxazid
Antidepressants Market Trends: What’s Defining The Industry’s Next Phase?
Major companies in the antidepressant market are increasingly focusing on introducing new drugs, such as ZURZUVAE (zuranolone) for treating postpartum depression (PPD), to maximize their market revenue. Postpartum depression (PPD) is a type of depression that can arise after childbirth, representing a serious mental health condition that affects both new mothers and fathers. For instance, in August 2023, Biogen Inc, a US-based biotechnology company, and Sage Therapeutics, Inc., a US-based biopharmaceutical company, launched ZURZUVAE (zuranolone), a 50 mg oral treatment for postpartum depression (PPD) in women. This launch signifies a substantial advancement, addressing PPD, a condition often underdiagnosed and undertreated. ZURZUVAE (zuranolone) serves as an oral treatment primarily for postpartum depression (PPD) and holds the distinction of being the first and only FDA-approved medication specifically designed for this condition.
Antidepressants Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the antidepressants market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol Myers Squibb Company, Abbott Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Takeda Pharmaceutical Co. Ltd., Eli Lilly and Company, Boehringer Ingelheim GmbH, H. Lundbeck AS, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Mylan N.V, Sun Pharmaceuticals Pvt. Ltd., Servier Laboratories, Sumitomo Dainippon Pharma Co., Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Allergan plc, Alkermes plc, Egis Pharmaceuticals plc, Forest Laboratories Inc.
View The Full Antidepressants Market Report:
Antidepressants Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the antidepressants market in 2025. Middle East is expected to be the largest growing region in the global antidepressants market during the forecast period. The regions covered in the antidepressants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
